ResearcherSichuan UniversityActive in the last 2 years

Wanrui Lv

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5104153721. Sources: OpenAlex.

Their work

Papers: 5
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 20

Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers · 2024: 1 paper

Papers 5

Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal a… Co-author DOI 10.1038/s41392-024-02031-8 ↗
A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyac146 ↗
Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case report. Co-author DOI 10.1186/s12883-023-03140-7 ↗
Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastatic pancreatic ductal adenocarcinoma: an o… Co-author DOI 10.21203/rs.3.rs-3677396/v1 ↗
Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a s… Co-author DOI 10.1136/bmjopen-2021-050558 ↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ke Cheng · 3 shared papers, 2023 · strength 0.56
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
- Paper A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreat… DOI 10.1093/oncolo/oyac146 ↗
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Junjie Xiong · 3 shared papers, 2023–2024 · strength 0.48
- Paper A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreat… DOI 10.1093/oncolo/oyac146 ↗
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Dan Cao · 2 shared papers, 2022–2023 · strength 0.44
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
- Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558 ↗
Rui Wang · 2 shared papers, 2023–2024 · strength 0.30
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Xi Chen · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
Jianping He · 1 shared paper, 2023 · strength 0.24
- Paper Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a c… DOI 10.1186/s12883-023-03140-7 ↗
Qiancheng Hu · 1 shared paper, 2022 · strength 0.20
- Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558 ↗
Xin Wang · 1 shared paper, 2022 · strength 0.20
- Paper Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanc… DOI 10.1136/bmjopen-2021-050558 ↗
Chen Chang · 1 shared paper, 2023 · strength 0.18
- Paper A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreat… DOI 10.1093/oncolo/oyac146 ↗
Dan Cao · 1 shared paper, 2023 · strength 0.18
- Paper A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreat… DOI 10.1093/oncolo/oyac146 ↗
Heqi Yang · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Xiaoying Li · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Dan Cao · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Yi Cheng · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Ke Cheng · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Bole Tian · 1 shared paper, 2024 · strength 0.15
- Paper Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally ad… DOI 10.1038/s41392-024-02031-8 ↗
Chengjian Zhao · 1 shared paper, 2023 · strength 0.14
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Zixing Huang · 1 shared paper, 2023 · strength 0.14
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Dan Cao · 1 shared paper, 2023 · strength 0.14
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗
Bole Tian · 1 shared paper, 2023 · strength 0.14
- Paper Toripalimab combined with albumin-paclitaxel plus gemcitabine as first-line treatment for locally advanced or metastati… DOI 10.21203/rs.3.rs-3677396/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.